menu

Medical Program: The Expanding Value of Biomarkers in NSCLC Treatment

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

The Expanding Value of Biomarkers in NSCLC Treatment

Program Information
Recommended
The Expanding Value of Biomarkers in NSCLC Treatment
RestartResume
New tools are emerging for oncologists as the research into biomarkers continues. How should you be utilizing these molecular signatures?
  • Sponsored by

  • Overview

    The treatment landscape for non-small cell lung cancer is continuing to expand, and playing a major role in clinical decision-making are biomarkers. Dr. Ross Camidge reveals the importance of these molecular signatures with Dr. Shira Johnson and how he applies them in practice. 

    Closing the Gaps in NSCLC is sponsored by Lilly. Content for this non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.

     

Facebook Comments

LIVE ON REACHMD RADIOBack to live radio

Loading...

Programs 7/20/19

Get a Dose of ReachMD in Your Inbox
and Practice Smarter Medicine

Stay current with the best in medical education.